NCT03382353

Brief Summary

By 2030, the global prevalence of Alzheimer's Disease (AD) is predicted to reach 65.7 million worldwide. Despite extensive research efforts, a cure for AD has not been identified. Recent studies on non-demented individuals have demonstrated the importance of a healthy lifestyle (physical exercise, healthy diet) and non pharmacological interventions (diet supplements) to delay the onset of the cognitive decline (Vemuri P et al., 2012). Given that AD is a multi-factorial disorder, some multi- component interventions at early stages could be the best strategy currently available to delay the AD onset. The aim of this study is to investigate the effects of combined non-pharmacological interventions, at different levels of intensity, on cognitive performance, on basic (hippocampal, brain ventricle volumes and white matter lesions) and advanced magnetic resonance imaging (MRI) markers (Resting-state Functional MRI, Probabilistic Diffusion Tensor Tractography

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 22, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

1.4 years

First QC Date

December 9, 2017

Last Update Submit

September 13, 2021

Conditions

Keywords

primary preventionSubjective Cognitive DeclineNeuroimagingAlzheimer's diseasenonpharmacological interventionsmultidomain lifestyle interventions

Outcome Measures

Primary Outcomes (1)

  • Cognitive functions

    Neuropsychological test performances

    12 months

Secondary Outcomes (3)

  • Basic imaging marker 1

    12 months

  • Basic imaging marker 2

    12 months

  • Basic imaging marker 3

    12 months

Other Outcomes (2)

  • Advanced imaging marker 1

    12 months

  • Advanced imaging marker 2

    12 months

Study Arms (3)

No Treatment (NT)

ACTIVE COMPARATOR

Educational training

Behavioral: Educational training

Partial Treatment (PT)

EXPERIMENTAL

Nutritional supplementation \& Counselling on a brain-healthy diet

Dietary Supplement: Nutritional supplementationBehavioral: Counselling on a brain-healthy diet

Full Treatment (FT)

EXPERIMENTAL

Nutritional supplementation \& Counselling on a brain-healthy diet \& Physical exercise training \& Computerized cognitive training

Dietary Supplement: Nutritional supplementationBehavioral: Counselling on a brain-healthy dietBehavioral: Physical exercise trainingBehavioral: Computerized cognitive training

Interventions

Nutritional supplementationDIETARY_SUPPLEMENT

Daily consumption of Tramiprosate (100 mg) for 1 year

Full Treatment (FT)Partial Treatment (PT)

16 educational lessons (twice a week): basic principles of different cognitive domains (e.g. memory, attention, perception) and educational DVD viewing.

No Treatment (NT)

4 lessons on the principles of Mediterranean Diet lead by a nutritionist, aimed to teach how to include brain-healthy foods in daily diet (e.g. antioxidant, omega-3 fatty acids and vitamins). Each participant will receive the educational material presented.

Full Treatment (FT)Partial Treatment (PT)

80 sessions of physical exercise supervised by a Fitness Training Expert with the aim of achieving 150 minutes of moderate-intensity physical activity per week

Full Treatment (FT)

16 cognitive training sessions (twice a week) supervised by a psychologist, aimed to improve Attention, Processing speed, Memory, Social skills and Intelligence using BrainHQ (www.brainhq.com).

Full Treatment (FT)

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 60 and 80 years;
  • presence of memory complaints

You may not qualify if:

  • objective cognitive impairment on standard neuropsychological testing;
  • history of psychiatric disorders or current clinically relevant depressive or anxious symptoms;
  • pacemakers, cochlear implant, metal inserts in the head or shoulders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Brescia, 25125, Italy

Location

Ospedale San Raffaele

Milan, 20132, Italy

Location

Related Publications (7)

  • Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012 Jan 24;78(4):241-9. doi: 10.1212/WNL.0b013e3182436598. Epub 2011 Dec 28.

    PMID: 22205763BACKGROUND
  • Cavedo E, Galluzzi S, Pievani M, Boccardi M, Frisoni GB. Norms for imaging markers of brain reserve. J Alzheimers Dis. 2012;31(3):623-33. doi: 10.3233/JAD-2012-111817.

    PMID: 22672878BACKGROUND
  • Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22. doi: 10.1073/pnas.1015950108. Epub 2011 Jan 31.

    PMID: 21282661BACKGROUND
  • Lampit A, Hallock H, Valenzuela M. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med. 2014 Nov 18;11(11):e1001756. doi: 10.1371/journal.pmed.1001756. eCollection 2014 Nov.

    PMID: 25405755BACKGROUND
  • Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.

    PMID: 21514248BACKGROUND
  • Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Roberts RO, Lowe VJ, Kantarci K, Senjem ML, Gunter JL, Boeve BF, Petersen RC, Jack CR Jr. Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol. 2012 Nov;72(5):730-8. doi: 10.1002/ana.23665.

    PMID: 23280791BACKGROUND
  • Rolandi E, Dodich A, Mandelli S, Canessa N, Ferrari C, Ribaldi F, Munaretto G, Ambrosi C, Gasparotti R, Violi D, Iannaccone S, Marcone A, Falini A, Frisoni GB, Galluzzi S, Cerami C, Cavedo E. Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial. Aging Clin Exp Res. 2025 May 14;37(1):151. doi: 10.1007/s40520-025-03062-z.

MeSH Terms

Conditions

Risk Reduction BehaviorAlzheimer Disease

Interventions

Dietary SupplementsTraining SupportExercise

Condition Hierarchy (Ancestors)

BehaviorDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesFinancial SupportEconomicsHealth Care Economics and OrganizationsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Enrica Cavedo, PhD

    IRCCS Centro San Giovanni di Dio Fatebenefratelli

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 9, 2017

First Posted

December 22, 2017

Study Start

January 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2018

Last Updated

September 14, 2021

Record last verified: 2021-09

Locations